🔴 LIVE from the Autumn Council Meeting in Leiden, The Netherlands 📸 The ERA Council is here to explore new ideas aimed at driving the ERA Community forward 🤝 By supporting each other, we can keep innovating and challenging our thinking!

https://t.co/6QTgHFUVTl

14/ ✨ Summary of the presentation On behalf of @ERAkidney social media team, Cristina Popa @NephroSeeker

🎉 We're proud to share the latest Impact Factors and CiteScores for our leading nephrology journals Nephrology Dialysis Transplantation (NDT) and Clinical Kidney Journal (CKJ). 🙏 Thanks to the exceptional contributions of our authors, reviewers, readers, and editorial board.

How will the #CONFIDENCE trial shape practice in #CKD + #T2D? I spoke with PI @AgarwalRajivMD after his #ERA25 late-breaker on why a sequential approach may be doing our patients a disservice Full episode: https://t.co/NirFzLDFYK #KidneyCompass #ERA25 #SGLT2i #finerenone

Thank you for helping boost nephrology beyond imagination at the most incredible @ERAkidney Congress ever! With over 10.000 attendees and phenomenal sessions. 🇦🇹

Special thanks for the huge support and extremely nice messages I have received from so many 👩🏻‍⚕️👩🏻‍⚕️👩🏻‍⚕️👩🏻‍⚕️ in #ERA2025

#Complement Activation in Secondary Thrombotic Microangiopathies (#TMA) ✅ Final version available in #OpenAccess in @NDTsocial ➡️ https://t.co/eu7sbHTs6f 🙏 experts, colleagues and friends; the @ERAkidney Immunonephrology Working Group; and @AKronbichler for your leadership!

#ERA25 #BeyondNephrology is over! Four days of immersive science 🧠, networking 🤝, and a lot of fun 🎉! Farewell to dear Wien 🇦🇹 with an immersive day in its cultural treasures 🎨🎶🏛️ and timeless charm ✨. Until next time! 💫📚🍷 See you in Glasgow 🏴󠁧󠁢󠁳󠁣󠁴󠁿 🥃

Last day of #ERA25 comes with interesting news, wrapped in a shiny methods package 🎁✨ Brought to us by @KristofferSkaar and Co

🤩Simultaneous publication for NUDGE CKD trial in @CircAHA #ERA25

Results of the SWEETSTONE TRIAL 🔥at #ERA25 #BeyondNephrology by Dr. Manuel Anderegg @Andereggman 🎯iSGLT2 ⬆️ urinary citrate! ❓Does this mean we can we treat stone formers with iSGLT2❓ 👉🏻The EMPASTONE trial will bring us the answer!

Should dialysate sodium (DNa) be high? Speaker 🎙️: Manfred Hecking Chair 💺: Lily Jakulj, Björn Meijers ✍️: Vaibhav Tiwari @drvt87

14/ Serious Adverse Events (Cardiovascular related hospitalization) #ERA25

⏩ 2nd presentation in Nephrology Innovations: Trials and Results #era25 Evaluating Cardiovascular Safety of Peroxisome Proliferator Activator Receptor-Gamma (PPAR-g) Agonist in Kidney Failure Patients receiving Peritoneal Dialysis (PROOF Trial) 🎤 Presented by Angela Yee-Moon

6/6 🏁 Take-homes 1️⃣ One-size-fits-all DNa = obsolete. 2️⃣ Target patient matched DNa (often 134-138 mEq/L) to neutralise diffusive Na. 3️⃣ Pair with online conductivity / Na-balance modules. 4️⃣ Randomised trials on DNa-guided therapy & hard outcomes are overdue

📣 LAST DAY at #ERA25! Read our Daily Congress Bulletin 👉 https://t.co/7BfxSrrI4M

Thomas Wekerle presented on bone marrow and regulatory T cells (Tregs) at #ERA25. Bone marrow transplantation is used in malignancy, with immune tolerance observed in these patients following kidney transplantation. Treg therapy induces chimerism without myelosuppression. Both

FC 11: The HD Rollercoaster 🎢 ✅ Starting with new systems to monitor intradialytic BP ❗️

#ERA25 #BeyondNephrology Next on Innovative Kidney Trials session🧠 1/ 🚨 A phase I/IIa trial of regulatory T cell therapy together with donor bone marrow infusion in HLA-mismatched kidney transplantation. It’s a novel approach to donor-specific tolerance in kidney transplant